Advances in Nutritional Management of Chronic Pancreatitis

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2000 Sep 12

PMID 10981031

Citations 2

Authors

J C SHEA

I K Hopper

P G Blanco

S D Freedman

Affiliations

Soon will be listed here.

Abstract

Nutrition has an important role in the management of chronic pancreatitis (CP), with two main goals for treatment of patients. The first goal is to provide optimal nutrition support and the second is to decrease pain by minimizing stimulation of the exocrine pancreas. Because cholecystokinin (CCK) stimulates secretion from the exocrine pancreas, one approach is to decrease CCK levels through modulation of diet. If postprandial pain is a limiting factor, alternative enteral therapies that minimally stimulate the pancreas may be beneficial. Nutritional counseling, antioxidants, and pancreatic enzymes may play a role in effective management of CP as well. In addition, because idiopathic CP is associated with cystic fibrosis gene mutations, therapies directed toward cystic fibrosis may also benefit these patients.

Citing Articles

Pharmacological challenges in chronic pancreatitis.

Olesen A, Brokjaer A, Fisher I, Larsen I World J Gastroenterol. 2013; 19(42):7302-7.

PMID: 24259961 PMC: 3831212. DOI: 10.3748/wjg.v19.i42.7302.

The management of acute and chronic pancreatitis.

Banks P, Conwell D, Toskes P Gastroenterol Hepatol (N Y). 2010; 6(2 Suppl 3):1-16.

PMID: 20567557 PMC: 2886461.

References

Freedman S, Katz M, Parker E, Laposata M, Urman M, Alvarez J . A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci U S A. 1999; 96(24):13995-4000. PMC: 24179. DOI: 10.1073/pnas.96.24.13995. View

Cohn J, Friedman K, Noone P, Knowles M, Silverman L, Jowell P . Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998; 339(10):653-8. DOI: 10.1056/NEJM199809033391002. View

Durbec J, SARLES H . Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreaitis and alcohol, protein and lipid consumption. Digestion. 1978; 18(5-6):337-50. DOI: 10.1159/000198221. View

Go V, Hofmann A, Summerskill W . Pancreozymin bioassay in man based on pancreatic enzyme secretion: potency of specific amino acids and other digestive products. J Clin Invest. 1970; 49(8):1558-64. PMC: 322635. DOI: 10.1172/JCI106373. View

Carlstedt-Duke J, Bronnegard M, Strandvik B . Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci U S A. 1986; 83(23):9202-6. PMC: 387103. DOI: 10.1073/pnas.83.23.9202. View

Spannagel A, Green G, Guan D, Liddle R, Faull K, Reeve Jr J . Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc Natl Acad Sci U S A. 1996; 93(9):4415-20. PMC: 39552. DOI: 10.1073/pnas.93.9.4415. View

Uden S, Acheson D, Reeves J, Worthington H, Hunt L, Brown S . Antioxidants, enzyme induction, and chronic pancreatitis: a reappraisal following studies in patients on anticonvulsants. Eur J Clin Nutr. 1988; 42(7):561-9. View

Collins F . Cystic fibrosis: molecular biology and therapeutic implications. Science. 1992; 256(5058):774-9. DOI: 10.1126/science.1375392. View

Gilljam H, Strandvik B, Ellin A, WIMAN L . Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis. Scand J Clin Lab Invest. 1986; 46(6):511-8. DOI: 10.3109/00365518609083706. View

10.

Whitcomb D, Gorry M, Preston R, Furey W, Sossenheimer M, Ulrich C . Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996; 14(2):141-5. DOI: 10.1038/ng1096-141. View

11.

Liddle R, Goldfine I, Williams J . Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology. 1984; 87(3):542-9. View

12.

Rose P, Fraine E, Hunt L, Acheson D, Braganza J . Dietary antioxidants and chronic pancreatitis. Hum Nutr Clin Nutr. 1986; 40(2):151-64. View

13.

Braganza J, Thomas A, Robinson A . Antioxidants to treat chronic pancreatitis in childhood? Case report and possible implications for pathogenesis. Int J Pancreatol. 1988; 3(2-3):209-16. DOI: 10.1007/BF02798933. View

14.

Kerem B, Rommens J, Buchanan J, Markiewicz D, Cox T, Chakravarti A . Identification of the cystic fibrosis gene: genetic analysis. Science. 1989; 245(4922):1073-80. DOI: 10.1126/science.2570460. View

15.

Roulet M, Frascarolo P, Rappaz I, Pilet M . Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr. 1998; 156(12):952-6. DOI: 10.1007/s004310050750. View

16.

Steer M, Waxman I, Freedman S . Chronic pancreatitis. N Engl J Med. 1995; 332(22):1482-90. DOI: 10.1056/NEJM199506013322206. View

17.

SARLES H, Augustine P, Laugier R, Mathew S, Dupuy P . Pancreatic lesions and modifications of pancreatic juice in tropical chronic pancreatitis (tropical calcific diabetes). Dig Dis Sci. 1994; 39(6):1337-44. DOI: 10.1007/BF02093802. View

18.

Malagelada J, Go V, Summerskill W . Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals. Dig Dis Sci. 1979; 24(2):101-10. DOI: 10.1007/BF01324736. View